Description: This session will take a deep dive into emerging mortality experience for long-term care policyholders over age 90. How do we sort fact from fiction when it comes to recent experience that is blurred by the pandemic? This session will look at actual experience of healthy and disabled policies before, during and after the pandemic to help actuaries set assumptions.

Description: Interest Maintenance Reserve ("IMR") has become a hot topic recently due to rising interest rates, causing decreases or even negative IMR balances for some insurers. This article aims to exam some new questions facing financial reporting actuaries: - How should negative IMR be treated for statutory reporting? - What are the other actuarial implications of negative IMR? - What have regulators done and/or plan to do about negative IMR? - What are potential mitigants?

Description: This article provides an introduction to group supervision and group capital and its importance in today's increasingly global insurance market. Additionally, the article examines the various methods used in practice for calculating group capital and the factors that companies should consider as they develop their group capital management strategy.

Description: Article describes best practices for teaching a course module that involves multiple parameters. A good example is hypothesis testing which requires consideration of the parameters, sample-size, population distribution, known variance and has as consequences whether a normal or t distribution should be used or whether non parametric methods are used. The articles recommends use of the Prime Implicant Normal Form as a means of teaching. It shows the superiority of this method over other forms such as heuristics, complete rules, or graduated approaches.

Description: The American Academy of Actuaries announces the inaugural Award for Research, to be awarded to an early career scholar for the best research from an actuarial perspective. The theme for this year is Climate Change/ Climate Risk.

Description: Sustainable operations under changes in accounting principles and solvency standards

Description: A summary recap of the recent SOA Health Conference held in Dallas, TX in June of 2025. With the intentional use of AI to assist with the summary, this article gives a good overview of the recent conference with personal commentary from one of the attendees.

Description: Modeling Approaches and Challenges focuses on approaches to real world simulation and the challenges and considerations in real world simulation. Topics include: A frequency domain approach to build realistic multi-horizon scenarios. (Ortec approach) Cascade models structure linking models for major asset classes and economic variables. (Moody’s approach) Overview of models, calibrations & approaches within the context of different use cases. Deterministic & stochastic approaches. Importance of model re-calibration flexibility. We will also discuss specific insights into considerations and challenges in real world simulation, which include topics like: Setting capital market assumptions and/or calibration targets. Assumptions about correlation and causality. Calibrating the model to capital markets assumptions. Validating the model against capital market assumptions. Role of history, market data and stylized facts. Importance of back testing. Calibrating the model to multiple investment horizons. Inclusion of alterative asset classes such as private equity, infrastructure, and direct real estate. Associated issues of limited data, illiquidity and greater uncertainty about calibration targets.

Description: Learn to utilize one of the most requested skills in the actuarial science job advertisements. During this webcast, discover the benefits of programming, how to identify and explain complex technical information and ways to create stunning visuals with ggplot2, which exceed the capabilities of Excel. With your webcast attendance, you will receive a document with detailed explanations, codes and underlying data. Enjoy exercises which allow the creation of fully reproducible solutions. This means an easy reproduction of all presented plots learned during this webcast. Register and take the next step toward building enticing visualizations.

Description: Actuaries historically modeled new launches in pharmaceuticals by anticipating the expected change to the market basket. This became more complicated with the recent launches of gene and cell therapies as they address rare diseases. Rare conditions have low total member volume to study and some do not currently have a diagnosis code to identify them within claims data. Addressing this modeling challenge has been growing more important in the recent years with the number of therapies launching. What has the health care industry, and more specifically health care, done to enhance modeling and how should this be altered for the future? Additionally, historic modeling has sometimes incorporated a level of direct medical treatment cost offsets where studies have shown lower treatment costs are achievable. Can gene and cell financial modeling include cost offsets as well? And if so, what are suggested precautions or limitations to this effort?